CVS Health (CVS) stock tumbles as earnings, guidance miss expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CVS Health (CVS) PT Lowered to $77 at BofA Securities
May 2, 2024 5:38 AM EDTBofA Securities analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $77.00 (from $95.00) while maintaining a Buy rating.
The analyst comments "Shares of CVS currently trade at 8x earnings, implying investors have substantial doubt the company can... More
CVS Health (CVS) Misses Q1 EPS by 38c; Lowers Outlook
May 1, 2024 6:34 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.33, $0.38 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $88.4 billion versus the consensus estimate of $89.33 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of $7.00, versus the consensus of... More
Fed meeting, Amazon results, struggling US consumers - what's moving markets
May 1, 2024 5:02 AM EDTInvesting.com -- The U.S. Federal Reserve concludes its latest policy-setting meeting later Wednesday, while Amazon's first-quarter results largely impressed. Crude prices have been hit by a large build in U.S. inventories, while Wall Street looks set to start the new month on a negative note.Â
1. Powell in focus as Fed meeting concludes
The Federal Reserve concludes its latest two-day policy meeting later in the session - the marquee event for markets this week.
The U.S. central bank is... More
CVS Health (CVS) PT Lowered to $85 at UBS
April 29, 2024 6:18 AM EDTUBS analyst Kevin Caliendo lowered the price target on CVS Health (NYSE: CVS) to $85.00 (from $90.00) while maintaining a Buy rating.
The analyst comments " Our FY24 EPS estimate of $8.00 (prev. $8.24) falls based on our elevated MLR forecast for the full year (+40bps).... More

